Abstract
Heart failure (HF) remains a major health problem that is frequently not optimally treated. Recently revised guidelines have defined optimal evidence-based therapy for several classes of medications. We compared performance of clinicians in a comprehensive HF clinic to clinicians in a general cardiovascular clinic (CV) during 2005 and early 2006. Methods: Records of 563 patients with an ejection fraction (EF) ≤ 35% and symptomatic HF were abstracted. Doses of diuretics, beta blockers, ACE inhibitors, and angiotensin receptor blockers (ARBs) were recorded and classified into dose ranges of low, moderate, or maximal and aldosterone antagonists (AA) and digoxin as present or absent.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
